Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Keiko Irishio"'
Autor:
Dai Aoki, Takato Ueoka, Mototoshi Ito, Yasuhiro Kato, Masahiro Misago, Shinichiro Nakao, Daisuke Tamai, Nobuyuki Kajiwara, Shinya Suezaki, Misaki Kageyama, Shinichiro Murakami, Keiko Irishio
Publikováno v:
International Journal of General Medicine
Dai Aoki,1,2 Nobuyuki Kajiwara,3,4 Keiko Irishio,5 Yasuhiro Kato,6 Shinya Suezaki,1 Misaki Kageyama,1 Masahiro Misago,1 Daisuke Tamai,7 Shinichiro Nakao,1 Takato Ueoka,1 Mototoshi Ito,1 Shinichiro Murakami1,4 1Department of Emergency and General Medi
Autor:
Ryoko Sumi, Yasuharu Imai, Masanori Nakahara, Kazuto Fukuda, Yoshitaka Yamaguchi, Keiko Irishio, Yasushi Matsumoto, Takumi Igura, Yoshiyuki Sawai, Yasuhisa Shinomura, Sachiyo Kogita, Michiyo Hattori
Publikováno v:
Kanzo. 58:486-493
Autor:
Yuki Makino, Rui Mizumoto, Nobuyuki Kajiwara, Tetsuo Takehara, Masanori Nakahara, Yoshiyuki Sawai, Tsugiko Oze, Norio Hayashi, Naoki Hiramatsu, Sinichiro Zushi, Sachiyo Kogita, Keiko Irishio, Sumio Kawata, Yasuharu Imai, Takumi Igura, Kazuto Fukuda, Yasushi Matsumoto
Publikováno v:
Hepatology Research. 44:1165-1171
Aim Renal damage has been reported as an important complication during combination treatment of peginterferon (PEG IFN), ribavirin (RBV) and telaprevir (TVR) for chronic hepatitis C. However, very little is known about this complication. We investiga
Autor:
Kazuhiro Katayama, Yukinori Yamada, Ryotaro Sakamori, Michio Kato, Takayuki Yakushijin, Eiji Mita, Shinji Tamura, Tomohide Tatsumi, Keiko Irishio, Hideki Hagiwara, Ryoko Yamada, Harumasa Yoshihara, Naoki Harada, Hayato Hikita, Masami Inada, Yuki Tahata, Norio Hayashi, Yasuharu Imai, Tsugiko Oze, Toshimitsu Hamasaki, Atsuo Inoue, Yuichi Yoshida, Naoki Morishita, Tetsuo Takehara, Toshifumi Ito, Takuya Miyagi, Taizo Hijioka, Naoki Hiramatsu
Publikováno v:
Journal of gastroenterology. 51(3)
Hyperbilirubinemia, mild or moderate, is a commonly observed laboratory abnormality in chronic hepatitis C patients treated with simeprevir with pegylated interferon (Peg-IFN) plus ribavirin. In this prospective, multicenter study, we aimed to invest
Autor:
Michiaki Myotoku, Keiko Irishio, Chiaki Iwamoto, Tomoko Shioishi, Emi Miyamoto, Kazunori Shimomura, Syunichi Kawaguchi, Yumi Tomida, Toshiko Inui, Natsuko Suemura, Chika Yohiro, Yuki Ihara, Akiko Nakanishi, Yoko Murayama
Publikováno v:
YAKUGAKU ZASSHI. 126:1003-1010
At the Municipal Ikeda Hospital, a system in which pharmacists stationed in one ward pharmacy dispense drugs to be administered by injection and injectable preparations delivered to patients' bedsides was introduced in April 2000. This system was aim
Autor:
Kazuto, Fukuda, Yasuharu, Imai, Naoki, Hiramatsu, Keiko, Irishio, Takumi, Igura, Yoshiyuki, Sawai, Sachiyo, Kogita, Yuki, Makino, Rui, Mizumoto, Yasushi, Matsumoto, Masanori, Nakahara, Sinichiro, Zushi, Nobuyuki, Kajiwara, Tsugiko, Oze, Sumio, Kawata, Norio, Hayashi, Tetsuo, Takehara
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 44(12)
Renal damage has been reported as an important complication during combination treatment of peginterferon (PEG IFN), ribavirin (RBV) and telaprevir (TVR) for chronic hepatitis C. However, very little is known about this complication. We investigated
Autor:
Keiko Irishio, Kenji Ikeda, Syunichi Kawaguchi, Yoshihiko Hirotani, Norio Hashimoto, Seiji Yamaguchi, Akiko Nakanishi, Yoko Murayama, Fumiko Koyama, Michiaki Myotoku
Publikováno v:
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 128(2)
We established the Terminal Care Study Group, consisting of physicians, pharmacists, and nurses, in September 2001, and developed the group into the Palliative Care Team. We have surveyed the state of concomitant medications immediately before and at